Purpose Obese patients present a challenge to safe general anesthesia because of impaired cardiopulmonary physiology and increased risks of aspiration and acute upper airway obstruction. Since studies are lacking regarding the postoperative effects on recovery from general anesthesia in morbidly obese patients, we conducted a systematic review and meta-analysis of recovery outcomes in morbidly obese patients who had undergone general anesthesia.Source We systematically searched the PubMed, EMBASE TM , Cochrane, and Scopus TM databases for randomized controlled trials that evaluated the outcome of anesthesia with desflurane, sevoflurane, isoflurane, or propofol in morbidly obese patients. Using a random effects model, we conducted meta-analyses to assess recovery times (eye opening, hand squeezing, tracheal extubation, and stating name or birth date), time to discharge from the postanesthesia care unit (PACU), and the incidence and severity of postoperative nausea and vomiting (PONV). Principal findings We reviewed results for 11 trials and found that patients given desflurane took less time: to respond to commands to open their eyes (weighted mean difference [WMD] -3.10 min; 95% confidence interval (CI): -5.13 to -1.08), to squeeze the investigator's hand (WMD -7.83 min; 95% CI: -8.81 to -6.84), to be prepared for tracheal extubation (WMD -3.88 min; 95%

Doctor shopping for zolpidem appears to be an important issue in Taiwan. Implementing a proper referral system with efficient data exchange by physician or pharmacist-led medication reconciliation process might reduce DSB.

No abstract

No abstract

No abstract

The overall results indicated that using rhTSH before radioiodine therapy resulted in a greater thyroid volume reduction than radioiodine therapy alone. An increased incidence of hypothyroidism was observed in patients receiving high-dose rhTSH. Low-dose rhTSH before radioiodine therapy is more efficacious than radioiodine therapy alone for treating nontoxic benign thyroid nodules.

Based on the results of this retrospective chart review, the present ARB therapeutic interchange program was successfully developed and implemented. This is the first study to establish the positive impact of a well-run ARB therapeutic interchange program in Taiwan.

We demonstrate Organic thin film transistors (OTFTs) with solution‐processed semiconductor, triethylsilylethynyl anthradithiophene (TES‐ADT), as the active layer materials are investigated. Bottom‐gate solution‐processed TES‐ADT OTFTs possess excellent performance with mobility of 0.05 cm2V−1s−1, current modulation of 4×106, sub‐threshold slope of 0.91 V/dec. and threshold voltage of −7.7 V on glass substrate. The reliability of device is evaluated and demonstrates good electrical performance uniformity and stability after bias stress. Particularly, the devices exhibit reversible degradation after vacuum annealing, shown it's environmental stability under air atmosphere. Moreover, the device integrability has been demonstrated with two transistors‐one capacitor (2T1C) array for display media driving such as organic light emitting diode (OLED).